dr. lal pathlabs management on q1 report card & fy22 outlook
Published Streamed 3 years ago • 1.2K plays • Length 19:43Download video MP4
Download video MP3
Similar videos
-
11:29
q1 review: dr lal pathlabs' ceo on earnings & outlook for upcoming quarters | bq prime
-
4:02
dr lal pathlabs md explains how co expects to beat last year's growth without price increase
-
9:57
q4 review | how dr. lal pathlabs plans to improve financials
-
20:30
laurus labs management on q1 report card & more
-
1:08
dr lal pathlabs' om manchanda on margins | bq prime
-
8:05
dr lal pathlabs | launching bengaluru reference lab
-
16:07
dr lal path labs' om manchanda exclusive on the changing landscape of diagnostics | the medicine box
-
22:46
in focus: dr lal path labs, srl diagnostics' ipo & apollo hospitals | the medicine box | cnbc-tv18
-
3:37
q3 numbers, outlook on non-covid business | bharath uppiliappan, dr lal pathlabs
-
10:12
diagnostics will continue to remain the mainstay within healthcare: dr lal path labs | cnbc tv18
-
26:18
q4 results: dr lal pathlabs' md on earnings & fy23 goals
-
3:57
expansion into new territories to boost growth: dr lal pathlabs
-
7:56
dr lal pathlabs vs alkem: which ipo is a better bet
-
22:44
dr lal path labs, fortis healthcare & apollo; know all about the biz strategy of healthcare giants
-
16:11
dr lal path labs' om manchanda: overall penetration levels have risen for diagnostics | cnbc-tv18
-
7:02
beneath the surface with dr. arvind lal, executive chairman, dr. lal path labs. ltd.
-
0:26
bharat ka vishwas - dr lal pathlabs - centre near you – hindi
-
0:28
dr lal path labs kherli
-
12:03
why is dr lal pathlabs share price falling? buying opportunity? hold or sell?
-
2:17
digital pathology at dr lal pathlabs
-
8:51
dr om manchanda on dr lal pathlabs' weak q3 earnings & outlook | bazaar corporate radar | cnbc-tv18
-
9:53
q2 review: dr lal pathlabs revenue grows by 12% | bq prime